Ian C. Wilkinson

发表

Fc-engineered antibodies with immune effector functions completely abolished

G. Hale, J. Fry, O. Qureshi, 2021, PloS one.

Systematic analysis of the varied designs of 819 therapeutic antibodies and Fc fusion proteins assigned international nonproprietary names

G. Hale, Ian C. Wilkinson, 2022, mAbs.

Solution structure of interleukin-1β bound to a potential therapeutic antibody

Ian C. Wilkinson, 2009 .

When monoclonal antibodies are not monospecific: Hybridomas frequently express additional functional variable regions

Jennifer Maynard, Marie-Paule Lefranc, Fortunato Ferrara, 2018, mAbs.

Development of a Bispecific Antibody Targeting Clinical Isolates of Acinetobacter baumannii.

J. Junge, B. Spellberg, Ian C. Wilkinson, 2023, The Journal of infectious diseases.

Monovalent IgG4 molecules

S. Fowler, D. Hayes, D. Corkill, 2013, mAbs.

Conformational Heterogeneity in Antibody-Protein Antigen Recognition

Vaclav Veverka, Robert Griffin, Mark D Carr, 2014, The Journal of Biological Chemistry.

High resolution NMR-based model for the structure of a scFv-IL-1beta complex: potential for NMR as a key tool in therapeutic antibody design and development.

Jiye Shi, M. Carr, F. Muskett, 2009, The Journal of biological chemistry.

High Resolution NMR-based Model for the Structure of a scFv-IL-1β Complex

Jiye Shi, M. Carr, F. Muskett, 2009, The Journal of Biological Chemistry.